We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Generex Biotechnology announced that 50 volunteers have been selected for participation in human clinical trials of the synthetic avian influenza vaccine under development by its wholly owned subsidiary, Antigen Express.
ViaCell announced results of its Phase I clinical trial evaluating its investigational umbilical cord blood transplant therapy, CB001, for treating patients with advanced hematologic cancers.
Arena Pharmaceuticals has completed patient enrollment in the first of three planned Phase III pivotal trials evaluating the efficacy and safety of its lead drug candidate, lorcaserin hydrochloride, for the treatment of obesity.
Amarin has completed the treatment phase of both the North American and European Phase III clinical trials of Miraxion for the treatment of Huntington's disease.
Psoriasis patients experienced a significant reduction in the signs of their disease when treated with Abbott's Humira (adalimumab), and they were significantly less likely to have their disease signs worsen when they used the drug continuously, new study results show.
Genta announced it has completed its response to the list of outstanding issues from the European Medicines Agency (EMEA) regarding its marketing authorization application (MAA) for Genasense (oblimersen sodium), its lead anticancer drug, for treatment of advanced melanoma.
Adeza announced that the FDA's Office of Orphan Products Development has granted orphan drug designation to Gestiva, the company's therapeutic candidate for the prevention of preterm birth in women with a history of preterm delivery.